Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
99.232,97
0,56%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Maia Biotechnology Inc (MAIA) Maia Biotechnology Inc (MAIA) Notizie

Maia Biotechnology Inc

MAIA
1,99
0,02 (1,02%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202422:51EDGAR2Form 8-K - Current report
23/12/202422:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202419:05EDGAR2Form 8-K - Current report
19/12/202414:47BWMAIA Biotechnology Announces Director Participation in..
16/12/202414:37BWMAIA Biotechnology Granted FDA Rare Pediatric Disease..
13/12/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202412:32EDGAR2Form 8-K - Current report
10/12/202400:00BWMAIA Biotechnology Announces Private Placement of..
03/12/202414:17BWMAIA Biotechnology Announces Expansion of Clinical Supply..
12/11/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202418:54EDGAR2Form D - Notice of Exempt Offering of Securities
08/11/202418:51EDGAR2Form 8-K - Current report
07/11/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202414:47BWMAIA Biotechnology Announces Participation by Director Stan..
05/11/202423:00EDGAR2Form 8-K - Current report
05/11/202415:45BWMAIA Biotechnology Announces Late-Breaking Abstract of..
04/11/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202411:17EDGAR2Form 8-K - Current report
29/10/202400:00BWMAIA Biotechnology Announces $2.44 Million Private Placement
26/10/202400:16EDGAR2Form SC 13D/A - General Statement of Acquisition of..
25/10/202423:12EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
25/10/202423:10EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
15/10/202414:15BWMAIA Biotechnology Announces Poster Presentation of Novel..
02/10/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202412:15EDGAR2Form 8-K - Current report
10/9/202412:00BWMAIA Biotechnology Announces Positive Survival Updates in..
04/9/202414:30BWMAIA Biotechnology to Present New Phase 2 Clinical Trial..
09/8/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/7/202423:05EDGAR2Form 8-K - Current report
23/7/202410:11BWMAIA Biotechnology Announces New Updates from Phase 2 Trial..
07/6/202418:31BWMAIA Biotechnology's Telomere Targeting Functionality is..
06/6/202420:57EDGAR2Form 8-K - Current report
06/6/202416:07BWMAIA Biotechnology Announces Year-to-Date Achievements and..
04/6/202422:06EDGAR2Form 8-K - Current report
04/6/202414:41BWMAIA Biotechnology Reveals New Clinical Data Showing THIO’s..
03/6/202422:05EDGAR2Form 8-K - Current report
29/5/202422:05EDGAR2Form 8-K - Current report
17/5/202414:37BWMAIA Biotechnology to Present at the BIO International..
16/5/202414:37BWMAIA Biotechnology Abstract Accepted for Poster Presentation..
15/5/202422:07EDGAR2Form 8-K - Current report
15/5/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/5/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202423:21EDGAR2Form 8-K - Current report
Apertura: 1,95 Min: 1,95 Max: 2,04
Chiusura: 1,97

La tua Cronologia

AMEX
MAIA
Maia Biotechnology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network